Medicare Enrolled
Dr. Gregory Macaluso, M.D.
Advanced Heart Failure and Transplant Cardiology Physician · Maywood, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Macaluso from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Macaluso?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Macaluso
Dr. Gregory Macaluso is an advanced heart failure and transplant cardiology physician in Maywood, IL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Macaluso performed 2,147 Medicare services across 1,108 unique beneficiaries.
Between the years covered by Open Payments, Dr. Macaluso received a total of $197,522 from 43 pharmaceutical and/or device companies across 896 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in advanced heart failure and transplant cardiology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Macaluso is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 21% volume in IL
$197,522 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,147
Medicare services
Top 21% in IL for advanced heart failure and transplant cardiology physician
1,108
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~126 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
317 | $135 | $247 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
282 | $97 | $167 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
261 | $99 | $230 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
190 | $179 | $653 |
| Remote monitoring of pulmonary artery pressure sensor This procedure involves the remote tracking of pressure readings from a sensor in the pulmonary artery over a period of up to 30 days. |
161 | $42 | $165 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
151 | $66 | $160 |
| Evaluation of lower heart chamber assist device Assessment of the function and status of a device that assists the lower chambers of the heart. |
141 | $34 | $172 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
121 | $6 | $33 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
108 | $44 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
79 | $144 | $429 |
| New patient office visit, complex (60-74 min) | 70 | $171 | $361 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 40 | $418 | $600 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
37 | $11 | $103 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
32 | $56 | $450 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
28 | $11 | $80 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
24 | $2 | $66 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
22 | $197 | $300 |
| Right heart catheterization A procedure where a thin, flexible tube is inserted into the right side of the heart to measure pressure and oxygen levels. |
20 | $107 | $891 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
17 | $156 | $900 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
13 | $1,067 | $3,785 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
11 | $363 | $2,121 |
| Exercise stress test A test that monitors the heart and lungs while the patient exercises to evaluate their function under physical stress. |
11 | $51 | $165 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $109 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
10.3% medium
88.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$197,522
Total received (2018-2024)
Avg $28,217/year across 7 years
Top 12% in IL for advanced heart failure and transplant cardiology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
896
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$159,197 (80.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$28,562 (14.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,763 (4.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$38,160
2023
$8,753
2022
$18,290
2021
$33,962
2020
$23,095
2019
$38,958
2018
$36,304
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lexicon Pharmaceuticals, Inc.
$26,144
AstraZeneca Pharmaceuticals LP
$10,067
Boehringer Ingelheim Pharmaceuticals, Inc.
$293
Novartis Pharmaceuticals Corporation
$257
Abbott Laboratories
$195
E.R. Squibb & Sons, L.L.C.
$169
Novo Nordisk Inc
$158
United Therapeutics Corporation
$140
Alnylam Pharmaceuticals Inc.
$139
ATRICURE, INC.
$128
Merck Sharp & Dohme LLC
$104
SCPHARMACEUTICALS INC.
$98
PFIZER INC.
$70
Boston Scientific Corporation
$67
Amgen Inc.
$44
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$35
Actelion Pharmaceuticals US, Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Chiesi USA, Inc.
$15
Top 3 companies account for 95.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$54,821
Abbott Laboratories
$46,913
AstraZeneca Pharmaceuticals LP
$32,758
Lexicon Pharmaceuticals, Inc.
$26,144
Medtronic Vascular, Inc.
$16,044
United Therapeutics Corporation
$8,756
Medtronic, Inc.
$2,470
PFIZER INC.
$956
Kestra Medical Technology Services, Inc.
$937
Boehringer Ingelheim Pharmaceuticals, Inc.
$897
Janssen Pharmaceuticals, Inc
$851
E.R. Squibb & Sons, L.L.C.
$718
Alnylam Pharmaceuticals Inc.
$612
ABIOMED
$545
ENDOTRONIX, INC.
$454
Actelion Pharmaceuticals US, Inc.
$393
Amgen Inc.
$387
ATRICURE, INC.
$367
Merck Sharp & Dohme LLC
$295
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$279
Novo Nordisk Inc
$227
Esperion Therapeutics, Inc.
$194
JenaValve Technology, Inc.
$162
Akcea Therapeutics, Inc.
$161
AtriCure, Inc.
$159
Boston Scientific Corporation
$130
SCPHARMACEUTICALS INC.
$122
W. L. Gore & Associates, Inc.
$122
La Jolla Pharmaceutical Company
$114
Bayer HealthCare Pharmaceuticals Inc.
$106
SANOFI-AVENTIS U.S. LLC
$99
Terumo Medical Corporation
$75
Regeneron Healthcare Solutions, Inc.
$42
Edwards Lifesciences Corporation
$38
Amarin Pharma Inc.
$36
Lundbeck LLC
$30
Inspire Medical Systems, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$17
ARALEZ PHARMACEUTICALS US INC.
$16
Chiesi USA, Inc.
$15
Merck Sharp & Dohme Corporation
$11
Cardiovascular Systems Inc.
$8
Top 3 companies account for 68.1% of all-time payments
Associated products mentioned in payments ›
2ND GEN CENTRIMAG PRIMARY CONSOLE · ANDEXXA · ANGIO-SEAL · ASSURITY · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) · Adempas · Assure WCD · BRILINTA · Bidil · BodyGuardian · CAMZYOS · CARDIOFORM Septal Occluder · CARDIOMEMS · CHANTIX · CORDELLA PULOMONARY ARTERY PRESSURE SENSOR · CardioMEMS HF System · CentriMag · Circulatory Support · Confirm Rx · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · ELIQUIS · ENSITE · ENSITE PRECISION · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · FARXIGA · FUROSCIX · GIAPREZA · GLIDEWIRE · Gallant CRT-D · GlideWire · HAWKONE · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · HeartMate Touch · HeartWare HVAD · INSPIRE · INVOKANA · Impella · Inpefa · JARDIANCE · JenaValve Pericardial TAVR System · KENGREAL · Kerendia · LEQVIO · LOKELMA · LifeVest · MULTAQ · MetaCross · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Ozempic · PASCAL · PRADAXA · PRALUENT · QUADRA ASSURA · Repatha · Rybelsus · SYNERGY ABLATION SYSTEM · TEGSEDI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TYVASO · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WINREVAIR · Wegovy · XARELTO · Xience Sierra Coronary Stent System · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in advanced heart failure and transplant cardiology physician and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Advanced heart failure and transplant cardiology physicians within 10 mi
15
Per 100K population
0.3
County median income
$81,797
Nearest hospital
LOYOLA UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Macaluso is a clinical cardiology specialist, with above-average Medicare volume (top 21% in IL), with speaking/promotional industry engagement in the top 12% of IL peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Macaluso experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Macaluso performed 317 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Macaluso receive payments from pharmaceutical companies?
Yes. Dr. Macaluso received a total of $197,522 from 43 companies across 896 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Macaluso's costs compare to other advanced heart failure and transplant cardiology physicians in Maywood?
Dr. Macaluso's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Macaluso) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Advanced Heart Failure And Transplant Cardiology Physicians in Maywood
Browse advanced heart failure and transplant cardiology physicians in Maywood ranked by procedure volume and transparency data.
Highest volume
Top Advanced Heart Failure And Transplant Cardiology Physicians in IL
Advanced heart failure and transplant cardiology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Advanced Heart Failure And Transplant Cardiology Physicians in IL
Which IL advanced heart failure and transplant cardiology physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology